Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 10;23(3):38.
doi: 10.1007/s12021-025-09729-2.

Prediction of Cerebrospinal Fluid (CSF) Pressure with Generative Adversarial Network Synthetic Plasma-CSF Biomarker Pairing

Affiliations

Prediction of Cerebrospinal Fluid (CSF) Pressure with Generative Adversarial Network Synthetic Plasma-CSF Biomarker Pairing

Phani Paladugu et al. Neuroinformatics. .

Abstract

Non-invasive intracranial pressure (ICP) monitoring can help clinicians safely and efficiently monitor spaceflight-associated neuro-ocular syndrome (SANS), idiopathic intracranial hypertension, and traumatic brain injury in astronauts. Current invasive ICP measurement techniques are unsuitable for austere environments like spaceflight. In this study, we explore the potential of plasma-derived cell-free RNA (cfRNA) biomarkers as non-invasive alternatives to cerebrospinal fluid (CSF) markers for ICP assessment. We conducted a secondary analysis of NASA's Open Science Data Repository datasets 363-364, focusing on plasma and CSF biomarkers related to ICP and neurovascular health. An ensemble model combining Support Vector Machine, Gradient Boosting Regressor, and Ridge Regression was developed to capture plasma-CSF biomarker relationships. To address limited sample size, we employed a Generative Adversarial Network (GAN) to generate synthetic plasma-CSF biomarker pairs, expanding the dataset from 29 to 279 samples. The model's performance was evaluated using Mean Squared Error (MSE) and validated against real biomarker data. The GAN-augmented ensemble model achieved high predictive accuracy with an MSE of 0.0044. Synthetic plasma-CSF pairs closely aligned with actual biomarker distributions, demonstrating their effectiveness in reducing overfitting and enhancing model robustness. Strong correlations between plasma-derived RNA biomarkers and corresponding CSF indicators support their potential as non-invasive proxies for ICP assessment. This study establishes a novel framework for non-invasive ICP monitoring using plasma cfRNA profiles enriched with GAN-generated synthetic data. The approach shows promise for both spaceflight and clinical applications, potentially broadening diagnostic capabilities for ICP-related conditions. However, further validation across diverse populations is necessary, along with careful consideration of bioethical and data security issues associated with synthetic data use in clinical diagnostics.

Keywords: Biomarker Prediction; Generative Adversarial Networks; Intracranial Pressure; Machine Learning in Medicine; Non-invasive Diagnostics.

PubMed Disclaimer

Conflict of interest statement

Declarations. Ethical Approval: Not applicable. This study was a secondary analysis of publicly available NASA datasets (Open Science Data Repository 363–364) and did not involve direct experimentation on human or animal subjects. No IRB approval or consent to participate/publish was required. Conflicts of interest: Andrew G. Lee has received compensation as a speaker for Amgen and Alexion and has served as a consultant for Viridian, Erythreal, Catalyst, AstraZeneca, Bristol Myers Squibb, Stoke, and the U.S. Department of Justice. He is also a consultant for NASA; however, the views expressed in this study are his own and do not necessarily reflect those of NASA or the U.S. government. Ram Jagadeesan is an employee of Cisco and holds stock in the company.

Similar articles

References

    1. Abbasi, M., Santos, B. P., Pereira, T. C., Sofia, R., Monteiro, N. R. C., Simões, C. J. V., Brito, R. M. M., Ribeiro, B., Oliveira, J. L., & Arrais, J. P. (2022). Designing optimized drug candidates with Generative Adversarial Network. Journal of Cheminformatics, 14(1), 40. https://doi.org/10.1186/s13321-022-00623-6 . Erratum.In:JCheminform.2022Aug11;14(1):53.10.1186/s13321-022-00631-6. - DOI - PubMed - PMC
    1. Albrecht LJ, Höwner A, Griewank K, et al (2022) Circulating cell-free messenger RNA enables non-invasive pan-tumour monitoring of melanoma therapy independent of the mutational genotype. Clinical and Translational Medicine 12. https://doi.org/10.1002/ctm2.1090
    1. Alhoraibi, L., Alghazzawi, D., & Alhebshi, R. (2024). Generative Adversarial Network-Based Data Augmentation for Enhancing Wireless Physical Layer Authentication. Sensors (Basel), 24(2), 641. https://doi.org/10.3390/s24020641 - DOI - PubMed
    1. Amal, S., Safarnejad, L., Omiye, J. A., Ghanzouri, I., Cabot, J. H., & Ross, E. G. (2022). Use of multi-modal data and machine learning to improve cardiovascular disease care. Frontiers in Cardiovascular Medicine, 27(9), 840262. https://doi.org/10.3389/fcvm.2022.840262 - DOI
    1. Arora, A. (2022). Generative adversarial networks and synthetic patient data: Current challenges and future perspectives. Future Healthcare Journal, 9(2), 190–193. https://doi.org/10.7861/fhj.2022-0013 - DOI - PubMed - PMC

MeSH terms

LinkOut - more resources